Fibroids

Transvaginal ultrasonography triage resulted in misclassification for more than one in 10 Black women, suggesting it is not a reliable strategy to identify Black women at risk for endometrial cancer, according to a diagnostic study.

The FDA has granted 510(k) clearance to Nesa Medtech’s Fibroid Mapping Reviewer Application to aid physicians in diagnosing symptomatic uterine fibroids and planning of interventional procedures, according to a company press release.

Linzagolix reduced uterine and fibroid volumes and improved pain and hemoglobin levels in women with uterine fibroids, according to multiple analyses of two phase 3 clinical trials.